0001209191-14-010161.txt : 20140213
0001209191-14-010161.hdr.sgml : 20140213
20140213123500
ACCESSION NUMBER: 0001209191-14-010161
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140211
FILED AS OF DATE: 20140213
DATE AS OF CHANGE: 20140213
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYNCH DANIEL
CENTRAL INDEX KEY: 0001177082
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 14604379
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-02-11
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001177082
LYNCH DANIEL
C/O ELEVEN BIOTHERAPEUTICS, INC.
215 FIRST STREET, SUITE 400
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock (restricted)
2014-02-11
4
A
0
70879
A
161430
D
The shares of restricted common stock vest over four years, with 6.25% of the shares vesting at the end of each successive three-month period after February 11, 2014.
The shares of restricted Common Stock were issued in consideration of services rendered and to be rendered by Mr. Lynch.
/s/ Daniel S. Lynch
2014-02-13